Wednesday, September 26, 2018
Company News: Page (1) of 1 - 04/16/18 Email this story to a friend. email article Print this page (Article printing at page facebook
Boehringer Ingelheim and Lilly announce an academic collaboration with University of Oxford to investigate the effects of Jardiance® in adults with chronic kidney disease
- University of Oxford, in partnership with the Duke Clinical Research Institute, to assess effect of Jardiance (empagliflozin) on heart and kidney disease in adults with chronic kidney disease- EMPA-...
(April 16, 2018)
This article is no longer available,but here are some related topics.

Page: 1

Related Keywords:USA, Inc.,Medicine,Diet,Disease,Surgery,healthcare,medical technologists,Surgery,Medication,Vitamins/Nutrition,Womens Health,Physician,Science,Medical,Business,Adults,Other,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter

Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines